← Back
Data updated: Mar 10, 2026
SCIENTURE
Cardiovascular
SCIENTURE is a pharmaceutical company focused on Cardiovascular. Key products include REZENOPY.
2024
Since
2
Drugs
-
Trials
3
Approved (2yr)
Key Drugs
Recent Activity
ARBLI 2026-02-18
Labeling
ARBLI 2025-03-13
Type 3 - New Dosage Form
REZENOPY 2024-04-19
Type 5 - New Formulation or New Manufacturer
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 100%
1 drugs
Pipeline Strength Pro
Loading...